Metraipolis › archive › dc_6fba337dfeba

Macrocyclic and Hydroxamate Ligands for 225Ac Radiopharmaceuticals: Evaluating SSTR2-Targeting Potential — Europe PMC PMID:41381404

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41381404
DOI: 10.1021/acs.inorgchem.5c04349
License (as archived): solo-consultazione
Archived: 2026-11-07T17:41:27.722Z
SHA-256 of the archived text: 5c185443a6744fede170cfbbd6d86e985940c2ae2c52de7ed997ecee06c81a9e
Stable URL of this page: https://metraipolis.com/documento/dc_6fba337dfeba

How to cite

Macrocyclic and Hydroxamate Ligands for 225Ac Radiopharmaceuticals: Evaluating SSTR2-Targeting Potential — Europe PMC PMID:41381404 — Europe PMC (en), https://europepmc.org/article/MED/41381404 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6fba337dfeba (Metraipolis archive dc_6fba337dfeba, sha256 5c185443a6744fede170cfbbd6d86e985940c2ae2c52de7ed997ecee06c81a9e)

BibTeX

@misc{dc6fba337dfeba,
  title = {Macrocyclic and Hydroxamate Ligands for 225Ac Radiopharmaceuticals: Evaluating SSTR2-Targeting Potential — Europe PMC PMID:41381404},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41381404},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6fba337dfeba; sha256 5c185443a6744fede170cfbbd6d86e985940c2ae2c52de7ed997ecee06c81a9e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41381404. Agents can read the archived copy with the MCP tool read_document.